Non-adherence to topical treatments for actinic keratosis

Patient Preference and Adherence

Volumn 8, Issue , 2013, Pages 35-41

  Shergill, Bav ^a   Zokaie, Simon ^b   Carr, Alison J ^c  

^a Worthing Hospital   (United Kingdom)

^b Leo Pharmaceuticals   (United Kingdom)

^c Hamell Communications   (United Kingdom)

Author keywords

Chronic skin disease; Patient behavior; Patient compliance; Treatment duration

Indexed keywords

DICLOFENAC; FLUOROURACIL; IMIQUIMOD; SALICYLIC ACID;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DRUG SELF ADMINISTRATION; DRUG UTILIZATION; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; ONLINE SYSTEM; PATIENT ATTITUDE; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; SCAR FORMATION; TELEPHONE; TREATMENT DURATION; TREATMENT OUTCOME; YOUNG ADULT; ARM; BACK; CLINICAL FEATURE; COMMUNITY ASSESSMENT; FACE; FOOT; HAND; LEG; SCALP; SHOULDER; TELEPHONE INTERVIEW; TREATMENT REFUSAL; TRUNK; UNITED KINGDOM;

EID: 84890467813     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S47126     Document Type: Article

References (23)

1. de Berker D, McGregor JM, Hughes, et al; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156(2): 222-230.
2. Berman B, Bienstock L, Kuritzky L, Mayeaux EJ Jr, Tyring SK; Primary Care Education Consortium; Texas Academy of Family Physicians. Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel. J Fam Prac. 2006;55(Suppl):1-8.
3. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1 Pt 2):8-10.
4. Glogau R. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42(1 Pt 2):23-24.
5. Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatology and Venereol. 2012(Suppl 3):61-67.
6. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7(4):231-236.
7. Feldman SR, Horn EJ, Balkrishnan R, et al; International Psoriasis Council. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol. 2008;59(5):1009-1016.
8. Yentzer B, Hick J, Williams L, et al. Adherence to a topical regimen of 5-fluorouracil, 0.5% cream for the treatment of actinic keratosis. Arch Dermatol. 2009;145(2):203-205.
9. Dreno B, Thiboutot D, Gollnick H, et al; Global Alliance to Improve Outcomes in Acne. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49(4):448-456.
10. Zaghloul SS, Goodfield MJD. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140(4):408-414.
11. Brown KK, Rehmus WE, Kilmball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607-613.
12. Lott R, Taylor SL, O'Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010;9(2):160-166.
13. Carr AJ, Hughes RA, Vincent K, Carr M, Thwaites C. The impact and implications of new treatments in arthritis: validation of a questionnaire to measure the real life effectiveness of medication. Rheumatology 2004;43(suppl):ii83
14. Carr AJ, Thompson PW, Cooper C. Factors affecting adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional study. Osteoporosis International 2006;17(11):1638-1644
15. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermat. 2004;51(2):212-216.
16. Straka RJ, Fish JT, Benson SR, Suh JT. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 1997; 17(1):126-132.
17. Llabre MM, Weaver KE, Duran RE, Antoni MH, McPherson-Baker S, Schneiderman N. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV positive patients. AIDS Patient Care STDS. 2006;20(10):701-711.
18. Lee MS, Lee HY, Kang SG, et al. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affective Disorders. 2010;123(1-3):216-221.
19. Bell DJ, Kapitao Y, Sikwese R, van Oosterhout JL, Lalloo DG. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Defic Syndr. 2007;45(5):560-563.
20. Shi L, Liu J, Walker P, Kalsekar A, Pawaskar M. Correlation beween adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.
21. Fletcher CV, Testa MA, Brundage RC, et al. Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. J Acquir Immune Defic Syndr. 2005; 40(3):301-306.
22. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003;2(3):219-228.
23. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement of properties of Skindex-16, a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105-110.